Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
3,142,571
-
Share change
-
+3,142,571
-
Total reported value
-
$31,331,000
-
Price per share
-
$9.97
-
Number of holders
-
13
-
Value change
-
+$31,331,000
-
Number of buys
-
13
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2017
As of 30 Sep 2017,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,142,571 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, Artal Group S.A., SABBY MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and TWO SIGMA SECURITIES, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.